Therefore, blocking CTLA4 in the context of inducing MMR deficiency in tumors can allow subdominant epitopes in those tumors to generate high-affinity T cell clones able to recognize even cryptic epitopes on tumor cells.51 Here, CTLA4 is linked to neoplasm.